Psychosocial impact of Peutz-Jeghers Syndrome

被引:0
作者
Alice Woo
Amit Sadana
David T. Mauger
Maria J. Baker
Terri Berk
Thomas J. McGarrity
机构
[1] Milton S. Hershey Medical Center,Penn State College of Medicine, Department of Medicine
[2] Milton S. Hershey Medical Center,Department of Medicine, Division of Gastroenterology/Hepatology
[3] Penn State University,Department of Health Evaluations and Sciences
[4] Milton S. Hershey Medical Center,Department of Medicine and Pediatrics
[5] Penn State Cancer Institute,Digestive Diseases Clinical Research Centre
[6] Milton S. Hershey Medical Center,undefined
[7] Familial GI Cancer Registry,undefined
[8] Mount Sinai Hospital,undefined
来源
Familial Cancer | 2009年 / 8卷
关键词
Peutz-Jeghers Syndrome; Psychosocial impact; Questionnaire development; CES-D; SF-36;
D O I
暂无
中图分类号
学科分类号
摘要
Peutz-Jeghers Syndrome (PJS) is an autosomal dominant inherited cancer predisposition syndrome and gastrointestinal hamartomatous polyposis syndrome characterized by the presence of distinct perioral freckling. To date, we have not found any tool that specifically assesses the psychosocial impact of PJS on patients. We developed a PJS quality of life questionnaire using expert opinions of 3 cancer genetic counselors and a survey of patients with PJS through recruitment of participants involved in a support group over the internet. We measured and compared our questionnaire results to the widely used Center for Epidemiologic Studies and Depression Scale (CES-D) and the Short Form 36 (SF-36). We recruited 38 patients for our study. Volunteers were mailed a consent form, the self-administered CES-D, SF-36 and our developed PJS questionnaire and were instructed to return the completed questionnaires by mail. Results showed that PJS patients suffer from mild depression even though physically they did not feel impacted by their condition compared to the general population. However, having PJS caused them to alter many important life decisions. The PJS Questionnaire correlated with data obtained from analysis of CES-D, as well as the SF-36. More uniquely, it provided specific information regarding the burden of disease and quality of life in patients affected with Peutz-Jeghers syndrome. Its ability to do so for other polyposis syndrome populations remains to be studied. These results are important in developing plan of care for these patients regarding genetic counseling and surveillance strategies for PJS patients.
引用
收藏
页码:59 / 65
页数:6
相关论文
共 74 条
[1]  
Schreibman IR(2005)The Hamartomatous Polyposis Syndromes: a clinical and molecular review Am J Gastroenterol 100 476-490
[2]  
Baker M(2001)Hamartomatous Polyposis Syndrome. Molecular genetics neoplastic risk and surveillance recommendations Ann Surg 8 319-327
[3]  
Amos CI(2006)Peutz-Jeghers Syndrome: clinicopathological molecule alterations Cell Mol Life Sci 63 2135-2144
[4]  
McGarrity TJ(2007)Hamartomatous Polyposis Syndromes Nat Clin Pract 4 492-502
[5]  
Wirtzfield DA(2004)Relative frequency and morphology of cancers in STK11 mutation carriers Gastroenterology 126 1788-1794
[6]  
Petrelli NJ(2006)Peutz-Jeghers Syndrome and management recommendations Clin Gastroenterol Hepatol 4 408-415
[7]  
Rodriquez-Bigas MA(2002)Polyposis Syndrome Clin Perspectives Gastroenterol Jan-Feb 51-59
[8]  
McGarrity TJ(1989)Cancer and the Peutz-Jeghers Syndrome Gut 30 1588-1590
[9]  
Amos C(2006)Frequency and spectrum of cancer in Peutz-Jeghers Syndrome Clin Cancer Res 12 3209-3215
[10]  
Zbuk KM(1987)Increased risk of cancer in Peutz-Jeghers Syndrome N Engl J Med 316 1511-1514